Found: 56
Select item for more details and to access through your institution.
Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 12, p. 1, doi. 10.1111/ijcp.14975
- By:
- Publication type:
- Article
Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies
- Published in:
- BJU International, 2017, v. 119, n. 5, p. 793, doi. 10.1111/bju.13744
- By:
- Publication type:
- Article
Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia - integrated data from 1 499 study participants.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 815, doi. 10.1111/bju.12926
- By:
- Publication type:
- Article
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 7, p. 551, doi. 10.1007/s40261-023-01286-3
- By:
- Publication type:
- Article
Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study.
- Published in:
- Surgical Technology International, 2021, v. 38, p. 1
- By:
- Publication type:
- Article
Factors associated with physician-reported treatment status of patients with osteoarthritis pain.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multimodal Treatment Patterns for Osteoarthritis and Their Relationship to Patient-Reported Pain Severity: A Cross-Sectional Survey in the United States.
- Published in:
- Journal of Pain Research, 2020, v. 13, p. 3415, doi. 10.2147/JPR.S285124
- By:
- Publication type:
- Article
Nerve Growth Factor Signaling and Its Contribution to Pain.
- Published in:
- Journal of Pain Research, 2020, v. 13, p. 1223, doi. 10.2147/JPR.S247472
- By:
- Publication type:
- Article
Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action.
- Published in:
- Therapeutic Advances in Urology, 2015, v. 7, n. 5, p. 249, doi. 10.1177/1756287215589238
- By:
- Publication type:
- Article
Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02759-0
- By:
- Publication type:
- Article
A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 796, doi. 10.1111/head.14741
- By:
- Publication type:
- Article
Pharmacotherapy for Stress Urinary Incontinence: Present and Future Options.
- Published in:
- Drugs, 2004, v. 64, n. 14, p. 1503, doi. 10.2165/00003495-200464140-00001
- By:
- Publication type:
- Article
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Characterizing 16-Week Responder Profiles Using Group-Based Trajectory Modeling in Over 4300 Clinical Trial Participants Receiving Pharmaceutical Treatment for Moderate to Severe Osteoarthritis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The handling of urinary incontinence in Danish general practices after distribution of guidelines and voiding diary reimbursement: an observational study.
- Published in:
- BMC Family Practice, 2004, v. 5, p. 13, doi. 10.1186/1471-2296-5-13
- By:
- Publication type:
- Article
Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries.
- Published in:
- Pain Practice, 2022, v. 22, n. 3, p. 359, doi. 10.1111/papr.13093
- By:
- Publication type:
- Article
Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 7, p. 1167, doi. 10.1002/art.41674
- By:
- Publication type:
- Article
A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1268, doi. 10.1093/oncolo/oyad188
- By:
- Publication type:
- Article
The not so hidden impact of interictal burden in migraine: A narrative review.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 01, doi. 10.3389/fneur.2022.1032103
- By:
- Publication type:
- Article
Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: a US focused review
- Published in:
- International Journal of Gynecology & Obstetrics, 2004, v. 86, p. S25, doi. 10.1016/j.ijgo.2004.05.008
- By:
- Publication type:
- Article
Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey.
- Published in:
- World Journal of Urology, 2015, v. 33, n. 5, p. 639, doi. 10.1007/s00345-014-1366-6
- By:
- Publication type:
- Article
Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies.
- Published in:
- World Journal of Urology, 2014, v. 32, n. 5, p. 1127, doi. 10.1007/s00345-014-1255-z
- By:
- Publication type:
- Article
Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 4, p. 1759, doi. 10.1007/s40744-021-00372-2
- By:
- Publication type:
- Article
Tadalafil once daily in the treatment of lower urinary tract symptoms ( LUTS) suggestive of benign prostatic hyperplasia ( BPH) in men without erectile dysfunction.
- Published in:
- BJU International, 2013, v. 112, n. 7, p. 990, doi. 10.1111/bju.12251
- By:
- Publication type:
- Article
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study.
- Published in:
- BJU International, 2011, v. 107, n. 7, p. 1110, doi. 10.1111/j.1464-410X.2010.09687.x
- By:
- Publication type:
- Article
Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment.
- Published in:
- BJU International, 2010, v. 105, n. 4, p. 502, doi. 10.1111/j.1464-410X.2009.08822.x
- By:
- Publication type:
- Article
Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label Extension.
- Published in:
- LUTS, 2012, v. 4, n. 3, p. 110, doi. 10.1111/j.1757-5672.2012.00144.x
- By:
- Publication type:
- Article
Tadalafil Administered Once Daily for Treatment of Lower Urinary Tract Symptoms in Korean men with Benign Prostatic Hyperplasia: Results from a Placebo-Controlled Pilot Study Using Tamsulosin as an Active Control.
- Published in:
- LUTS, 2011, v. 3, n. 2, p. 86, doi. 10.1111/j.1757-5672.2011.00088.x
- By:
- Publication type:
- Article
Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
- Published in:
- BMC Urology, 2012, v. 12, n. 1, p. 30, doi. 10.1186/1471-2490-12-30
- By:
- Publication type:
- Article
Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
- Published in:
- BMC Urology, 2008, v. 8, p. 1, doi. 10.1186/1471-2490-8-2
- By:
- Publication type:
- Article
Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis.
- Published in:
- Advances in Rheumatology, 2024, v. 64, n. 1, p. 1, doi. 10.1186/s42358-024-00358-y
- By:
- Publication type:
- Article
Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial.
- Published in:
- Pain & Therapy, 2022, v. 11, n. 4, p. 1267, doi. 10.1007/s40122-022-00424-7
- By:
- Publication type:
- Article
Satisfaction with Medications Prescribed for Osteoarthritis: A Cross-Sectional Survey of Patients and Their Physicians in the United States.
- Published in:
- Pain & Therapy, 2022, v. 11, n. 1, p. 191, doi. 10.1007/s40122-021-00350-0
- By:
- Publication type:
- Article
Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis”.
- Published in:
- Journal of Anaesthesiology Clinical Pharmacology, 2018, v. 34, n. 4, p. 548, doi. 10.4103/joacp.JOACP_155_18
- By:
- Publication type:
- Article
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 878, doi. 10.1002/cpt.2842
- By:
- Publication type:
- Article
Urinary incontinence during pregnancy and 1 year after delivery in primiparous women compared with a control group of nulliparous women.
- Published in:
- Neurourology & Urodynamics, 2012, v. 31, n. 4, p. 475, doi. 10.1002/nau.21221
- By:
- Publication type:
- Article
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action.
- Published in:
- Neurourology & Urodynamics, 2011, v. 30, n. 3, p. 292, doi. 10.1002/nau.20999
- By:
- Publication type:
- Article
Reductions in stress urinary incontinence episodes: What is clinically important for Women?
- Published in:
- Neurourology & Urodynamics, 2010, v. 29, n. 3, p. 344, doi. 10.1002/nau.20744
- By:
- Publication type:
- Article
The risk of lower urinary tract symptoms five years after the first delivery*.
- Published in:
- Neurourology & Urodynamics, 2002, v. 21, n. 1, p. 2, doi. 10.1002/nau.2198
- By:
- Publication type:
- Article
Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and Satisfaction.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 7, p. 2733, doi. 10.3390/jcm12072733
- By:
- Publication type:
- Article
Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic Surgeons.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 589, doi. 10.3390/jcm12020589
- By:
- Publication type:
- Article
Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysis.
- Published in:
- European Journal of Pain, 2022, v. 26, n. 3, p. 648, doi. 10.1002/ejp.1892
- By:
- Publication type:
- Article
Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
- Published in:
- European Journal of Pain, 2021, v. 25, n. 7, p. 1525, doi. 10.1002/ejp.1764
- By:
- Publication type:
- Article
Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies.
- Published in:
- Health & Quality of Life Outcomes, 2010, v. 8, p. 131, doi. 10.1186/1477-7525-8-131
- By:
- Publication type:
- Article
The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis.
- Published in:
- World Journal of Men's Health, 2014, v. 32, n. 1, p. 28, doi. 10.5534/wjmh.2014.32.1.28
- By:
- Publication type:
- Article
Efficacy and safety of tadalafil 5 mg once‐daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double‐blind, parallel, placebo‐ and tamsulosin‐controlled study
- Published in:
- International Journal of Urology, 2019, v. 26, n. 2, p. 192, doi. 10.1111/iju.13828
- By:
- Publication type:
- Article
Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo
- Published in:
- International Journal of Urology, 2015, v. 22, n. 6, p. 582, doi. 10.1111/iju.12741
- By:
- Publication type:
- Article
Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies.
- Published in:
- International Journal of Urology, 2015, v. 22, n. 4, p. 378, doi. 10.1111/iju.12699
- By:
- Publication type:
- Article